ES504388A0 - Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico. - Google Patents

Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico.

Info

Publication number
ES504388A0
ES504388A0 ES504388A ES504388A ES504388A0 ES 504388 A0 ES504388 A0 ES 504388A0 ES 504388 A ES504388 A ES 504388A ES 504388 A ES504388 A ES 504388A ES 504388 A0 ES504388 A0 ES 504388A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
hygroscopic salts
hydroxybutric acid
hydroxybutric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES504388A
Other languages
English (en)
Other versions
ES8306360A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803049869 external-priority patent/DE3049869A1/de
Application filed by Individual filed Critical Individual
Publication of ES504388A0 publication Critical patent/ES504388A0/es
Publication of ES8306360A1 publication Critical patent/ES8306360A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
ES504388A 1980-07-17 1981-07-16 Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico. Expired ES8306360A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3027390 1980-07-17
DE19803049869 DE3049869A1 (de) 1980-11-20 1980-11-20 Erdalkalisalze der 4-hydroxybuttersaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES504388A0 true ES504388A0 (es) 1983-06-01
ES8306360A1 ES8306360A1 (es) 1983-06-01

Family

ID=25786727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504388A Expired ES8306360A1 (es) 1980-07-17 1981-07-16 Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico.

Country Status (5)

Country Link
US (1) US4393236A (es)
EP (1) EP0044801B1 (es)
AU (1) AU7303981A (es)
DK (1) DK283081A (es)
ES (1) ES8306360A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217783B (it) * 1988-06-03 1990-03-30 Farmaceutico Ct S R L Lab Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
ES2058023B1 (es) * 1992-10-29 1995-10-01 Koehler Chemie Dr Franz Derivados del acido 4-hidroxi-butirico.
GB2299992A (en) * 1995-04-20 1996-10-23 Willem Jacob Serfontein Complexes of magnesium and calcium
EP1140061B1 (en) 1998-12-23 2003-05-02 Orphan Medical Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
EP1316309A1 (en) * 1998-12-23 2003-06-04 Orphan Medical Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
AU2003276960A1 (en) * 2002-06-13 2003-12-31 Novartis Ag Calcium salts of indole derived statins
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US8778398B2 (en) * 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8771735B2 (en) * 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
US8410304B2 (en) * 2009-04-15 2013-04-02 Norac Pharma Process for preparing gamma-hydroxybutyrate
US8461197B2 (en) 2009-04-23 2013-06-11 Concert Pharmaceuticals, Inc. 4-hydroxybutyric acid analogs
US20120076865A1 (en) 2010-03-24 2012-03-29 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
MX355742B (es) 2011-02-14 2018-04-26 Concert Pharmaceuticals Inc Análogos deuterados del ácido 4-hidroxibutírico.
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9050302B2 (en) 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11666546B2 (en) 2017-12-18 2023-06-06 Tris Pharma, Inc GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
WO2019126218A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
AU2019383389A1 (en) 2018-11-19 2021-05-06 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
CN109369372A (zh) * 2018-11-28 2019-02-22 上海欣海国际贸易有限公司 一种制备3-羟基丁酸盐的方法
CA3127871A1 (en) 2019-03-01 2020-09-10 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
CN112778123A (zh) * 2021-01-19 2021-05-11 宁波酶赛生物工程有限公司 一种3-羟基丁酸钠晶型及其制备方法和应用
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
WO2024163966A1 (en) 2023-02-03 2024-08-08 Tris Pharma, Inc. Low sodium oxybate once nightly composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA465270A (en) * 1950-05-23 Moore Kirk Philip Process for the preparation of pure calcium alpha hydroxyisobutyrate and pure alpha hydroxyisobutyric acid
GB922029A (en) * 1960-05-19 1963-03-27 Equilibre Biolog L Therapeutic composition

Also Published As

Publication number Publication date
DK283081A (da) 1982-01-18
EP0044801A1 (de) 1982-01-27
EP0044801B1 (de) 1984-02-15
AU7303981A (en) 1982-01-21
ES8306360A1 (es) 1983-06-01
US4393236A (en) 1983-07-12

Similar Documents

Publication Publication Date Title
ES504388A0 (es) Procedimiento para la preparacion de sales no higroscopicas del acido 4-hidroxibutirico.
ES515426A0 (es) Procedimiento para la obtencion de compuestos del acido 7 b-aminotiadiazolilacetilamino-3-amoniometil-3-cefem-4-carboxilico.
ES523239A0 (es) Procedimiento para preparar derivados del acido oxalico de efectos quimiluminiscentes.
ES507811A0 (es) Procedimiento para preparar sales de acido 5,5'-azobis-salicico.
ES498793A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido 1-(ciclohexil)-4-aril--4-piperidincarboxilico.
ES521337A0 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES500253A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido 2-penem-3-carboxilico.
ES521430A0 (es) Un procedimiento para la preparacion de derivados del acido tetrahidrofurancarboxilico.
ES518137A0 (es) Procedimiento para la preparacion de n-piridil-amidas de acido 1-fenil-ciclopentancarboxilico.
ES502828A0 (es) Un procedimiento para la preparacion de derivados del acido penen-3-carboxilico.
ES516590A0 (es) Procedimiento para la obtencion de esteres del acido 7 2(2-amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido)-3-cefem-4-carboxilico.
ES500032A0 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-azabiciclo (3,2,0) hept-2-en-2-carboxilico.
ES489186A0 (es) Un procedimiento para la preparacion de derivados del acido penicilamico 6-b-sustituidos.
ES523664A0 (es) Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico.
ES493517A0 (es) Procedimiento para la preparacion de anilidas de acido tio- glicolico, fungicidas
ES504287A0 (es) Un procedimiento para la preparacion de derivados del acido monico.
ES506798A0 (es) Un procedimiento para la preparacion de derivados del acido amino ciclopropilcarboxilico.
ES498717A0 (es) Un procedimiento para la preparacion de derivados del acido 2-b-clorometil-2&-metilpenam-3&-carboxilico.
ES525238A0 (es) Un procedimiento para la preparacion de derivados del acido penicilanico 6alfa-o-6beta-sustituidos.
ES500585A0 (es) Un procedimiento para la preparacion de derivados de acido 2-(2-cianoetil)-2-benzoilamino-alcanoicos.
ES511759A0 (es) Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico.
ES502829A0 (es) Un procedimiento para la preparacion de derivados del acido penem-3-carboxilico.
ES502952A0 (es) Procedimiento para la obtencion de amidas de acido 1,4-dihi-dropiridin-4-carboxilico
ES495751A0 (es) Un procedimiento para la preparacion de derivados del acido feniloxiacetico.
ES513963A0 (es) Procedimiento para la obtencion de compuestos del acido 7b-aminotriazolilacetilamino-3-cefem-4-carboxilico.